““Short”” thrombelastography as a test of platelet reactivity in response to antiplatelet therapy: Validation and reproducibility

By Sambu Nalyaka   Hobson Alex   Curzen Nick  

Platelets, Vol. 22, Iss. 3, 2011-05 ,pp. : 210-216

Informa Healthcare

Access to resources Recommend Favorite

Monitoring antiplatelet therapy with point-of-care platelet function assays: a review of the evidence

By van Werkum Jochem W   Hackeng Christian M   Smit Jaap-Jan J   van’’t Hof Arnoud WJ   Verheugt Freek WA   ten Berg Jurriëën M  

Future Cardiology, Vol. 4, Iss. 1, 2008-01 ,pp. : 33-55

Future Medicine

Access to resources Recommend Favorite

A paradigm shift in anti-platelet therapy?

By Bonello L.   Barragan P.   Paganelli F.  

Platelets, Vol. 19, Iss. 8, 2008-12 ,pp. : 562-564

Informa Healthcare

Access to resources Recommend Favorite

Increased risk of minor bleeding and antiplatelet therapy cessation in patients with acute coronary syndromes and low on-aspirin platelet reactivity. A prospective cohort study

By Huczek Zenon  

Journal of Thrombosis and Thrombolysis, Vol. 36, Iss. 1, 2013-07 ,pp. : 22-30

Springer Publishing Company

Access to resources Recommend Favorite

Triple Therapy Versus Dual Antiplatelet Therapy for Patients with Atrial Fibrillation and Acute Coronary Syndromes: A Systematic Literature Review

By  

Current Cardiology Reviews, Vol. 13, Iss. 4, 2017-10 ,pp. : 325-333

Bentham Science Publishers

Access to resources Recommend Favorite